BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 18677040)

  • 1. Sensitivity of different dose scoring methods on organ-specific neutron dose calculations in proton therapy.
    Jarlskog CZ; Paganetti H
    Phys Med Biol; 2008 Sep; 53(17):4523-32. PubMed ID: 18677040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weighting of secondary radiations in organ dose calculations.
    Siiskonen T; Tapiovaara M
    Radiat Prot Dosimetry; 2010 Sep; 141(1):18-26. PubMed ID: 20478895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective quality factors for neutrons based on the revised ICRP/ICRU recommendations.
    Veinot KG; Hertel NE
    Radiat Prot Dosimetry; 2005; 115(1-4):536-41. PubMed ID: 16381781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simulation of organ-specific patient effective dose due to secondary neutrons in proton radiation treatment.
    Jiang H; Wang B; Xu XG; Suit HD; Paganetti H
    Phys Med Biol; 2005 Sep; 50(18):4337-53. PubMed ID: 16148397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutron fluence-to-dose conversion coefficients for embryo and fetus.
    Chen J; Meyerhof D; Vlahovich S
    Radiat Prot Dosimetry; 2004; 110(1-4):693-8. PubMed ID: 15353732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutron shielding calculations in a proton therapy facility based on Monte Carlo simulations and analytical models: criterion for selecting the method of choice.
    Titt U; Newhauser WD
    Radiat Prot Dosimetry; 2005; 115(1-4):144-8. PubMed ID: 16381702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2007 recommendations of the ICRP change basis for estimation of the effective dose: what is the impact on radiation dose assessment of patient and personnel?
    Boetticher Hv; Lachmund J; Looe HK; Hoffmann W; Poppe B
    Rofo; 2008 May; 180(5):391-5. PubMed ID: 18438741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutron-fluence-to-dose conversion coefficients in an anthropomorphic phantom.
    Alghamdi AA; Ma A; Tzortzis M; Spyrou NM
    Radiat Prot Dosimetry; 2005; 115(1-4):606-11. PubMed ID: 16381792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of whole-body phantom designs to estimate organ equivalent neutron doses for secondary cancer risk assessment in proton therapy.
    Moteabbed M; Geyer A; Drenkhahn R; Bolch WE; Paganetti H
    Phys Med Biol; 2012 Jan; 57(2):499-515. PubMed ID: 22217682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between effective doses for voxel-based and stylized exposure models from photon and electron irradiation.
    Kramer R; Khoury HJ; Vieira JW
    Phys Med Biol; 2005 Nov; 50(21):5105-26. PubMed ID: 16237244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of neutron fluence to organ dose conversion coefficients in the ORNL analytical adult phantom.
    Miri Hakimabad H; Rafat Motavalli L; Karimi Shahri K
    J Radiol Prot; 2009 Mar; 29(1):51-60. PubMed ID: 19225185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetry of clinical neutron and proton beams: an overview of recommendations.
    Vynckier S; ;
    Radiat Prot Dosimetry; 2004; 110(1-4):565-72. PubMed ID: 15353710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement and Monte Carlo modelling of the JRC 241Am-Li(alpha,n) source spectrum.
    Tagziria H; Wiegel B; Klein H; Knauf K; Wittstock J; Zimbal A
    Radiat Prot Dosimetry; 2004; 110(1-4):129-34. PubMed ID: 15353635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monte Carlo investigation of collimator scatter of proton-therapy beams produced using the passive scattering method.
    Titt U; Zheng Y; Vassiliev ON; Newhauser WD
    Phys Med Biol; 2008 Jan; 53(2):487-504. PubMed ID: 18185001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implementation of full Monte Carlo dose calculation in proton beam therapy.
    Paganetti H; Jiang H; Parodi K; Slopsema R; Engelsman M
    Phys Med Biol; 2008 Sep; 53(17):4825-53. PubMed ID: 18701772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consideration of the ICRP 2006 revised tissue weighting factors on age-dependent values of the effective dose for external photons.
    Lee C; Lee C; Han EY; Bolch WE
    Phys Med Biol; 2007 Jan; 52(1):41-58. PubMed ID: 17183127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Options for the modified radiation weighting factor of neutrons.
    Kellerer AM; Leuthold G; Mares V; Schraube H
    Radiat Prot Dosimetry; 2004; 109(3):181-8. PubMed ID: 15254321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calculations of neutron dose equivalent exposures from range-modulated proton therapy beams.
    Polf JC; Newhauser WD
    Phys Med Biol; 2005 Aug; 50(16):3859-73. PubMed ID: 16077232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of organ-specific neutron equivalent doses in proton therapy using computational whole-body age-dependent voxel phantoms.
    Zacharatou Jarlskog C; Lee C; Bolch WE; Xu XG; Paganetti H
    Phys Med Biol; 2008 Feb; 53(3):693-717. PubMed ID: 18199910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standard fields of old neutron sources--parameters and traceability.
    Józefowicz K; Golnik N; Zielczyński M;
    Radiat Prot Dosimetry; 2004; 110(1-4):107-10. PubMed ID: 15353631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.